Services
services
Core business
of Goodwill
In-Licensing
To continuously expand our portfolio of branded healthcare products
Production
Of solid, sachet and liquid forms
Local representation
For companies who are willing to enter or to strengthen their position in our markets
CDMO Services
Offering end-to-end services in GMP environment for small- to large-scale batch sizes.
Logistics
GDP pre-wholesale and wholesale services
R&D, NPD
In related healthcare fields
We strongly believe that through collaborations and partnerships, we are capable to bring innovative solutions to patients. We are open to discuss opportunities with further partners to expand our pipeline and product portfolio.
We offer sales, marketing, pre-wholesale, logistics services of pharmaceutical products and food supplements with a sales team providing full coverage in Hungary in the following areas: rheumatology, infectious diseases, neurology, gastroenterology, ear-nose-throat, cough and cold, metabolism, allergy/immunology, urology, orthopedy, traumatology, andrology, psychiatry, dentistry and the GP segment.
Central and Eastern Europe, Hungary & the Balkans Goodwill Pharma delivers end-to-end acquisition and lifecycle management solutions for mature pharmaceutical products and brands across Central and Eastern Europe, with particularly deep expertise in Hungary and the Balkan region. We support originator and multinational pharmaceutical companies not only through full commercial, sales, and marketing management, but also—where strategically appropriate—through the acquisition and complete takeover of pharmaceutical brands. This includes brand transfer, in-licensing or acquisition, relaunch, long-term maintenance, and value optimization at both local and regional levels.
Our proven track record includes successful collaborations with leading global pharmaceutical companies such as Recordati and Novartis, as well as previous long-term cooperation with MSD and GSK. These partnerships reflect our capability to manage complex portfolios and sustain mature brands across multiple therapeutic areas. Goodwill Pharma operates with fully established infrastructure, including regulatory affairs, pharmacovigilance, GxP-compliant quality assurance, supply chain management, distribution, and experienced local commercial teams. We are therapeutically agnostic and open to cooperation across all therapy areas. This integrated model creates value because we provide complex, end-to-end solutions under one organization. Our highly experienced expert teams ensure the optimal maintenance, compliance, and long-term sustainability of mature pharmaceutical products, even in competitive or late-stage lifecycle environments. With decades of hands-on experience, Goodwill Pharma is among the most experienced pharmaceutical operators in Hungary and the Balkan region, combining deep local market knowledge with regional execution strength. We are a trusted partner for companies seeking brand acquisition, lifecycle management, and sustained commercial performance in Central and Eastern Europe.
Solid, sachet, liquid forms
ProductionOur comprehensive offerings cover also primary and secondary packaging, small batch manufacturing, GMP laboratory analyses, even co-development of new ideas if needed. Whether you’re launching a new product or seeking to expand your product line, we’re here to support you with comprehensive services that exceed expectations and drive success
We strongly believe that through collaborations and partnerships, we are capable to bring innovative solutions to patients. We are open to discuss opportunities with further partners to expand our pipeline and product portfolio.
We offer sales, marketing, pre-wholesale, logistics services of pharmaceutical products and food supplements with a sales team providing full coverage in Hungary in the following areas: rheumatology, infectious diseases, neurology, gastroenterology, ear-nose-throat, cough and cold, metabolism, allergy/immunology, urology, orthopedy, traumatology, andrology, psychiatry, dentistry and the GP segment.
CDMO
At Goodwill Pharma, we are committed to providing comprehensive CDMO services that support our partners throughout the entire pharmaceutical lifecycle. From early-stage development to large-scale commercial manufacturing, we offer tailored solutions that meet the highest industry standards.
We specialize in creating innovative formulations that enhance drug efficacy, stability, and patient compliance.
Process Development & Optimization
Our team of experts utilizes state-of-the-art technologies to develop scalable and cost-effective manufacturing processes.
Analytical Services
We provide robust analytical development and validation to ensure regulatory compliance and product quality.
Clinical and Commercial Manufacturing
Our GMP-certified facilities support seamless scale-up from clinical trials to commercial production.
Regulatory Support
We assist our partners in navigating complex regulatory landscapes to achieve successful market approvals.
Expanding Partnerships at
Goodwill PharmaGoodwill Pharma continues to strengthen its presence in the Central and Eastern European region by expanding its network with new, strategically significant Contract Manufacturing Organization collaborations. Our newest partners include Hemofarm, Galenika, Rhei Life, Polpharma és az Alkaloid, all prominent pharmaceutical manufacturers with whom we are working on complex, high-standard projects.
Our manufacturing sites in Hungary and Serbia operate in GMP-certified environments, covering the full production process from quality-assured manufacturing to secondary packaging. With our modern technological infrastructure and flexible capacities, we ensure reliable, precise, and predictable support for partners with varying volumes and levels of complexity.
New services
Our authorised importation platform covers the full EU GMP Annex 21 scope for imported medicinal products, including a designated physical importation site, sampling of each batch and GMP‑compliant quarantine management. Each imported batch is subject to EU‑standard quality control testing and EU batch release in accordance with EU GMP Annex 16 and the registered marketing authorisation. We provide controlled storage for imported products, retention and stability samples, with full traceability and stability follow‑up, and are preparing serialisation capability in line with EU requirements.
2. Primary and secondary packaging
Manufacturing authorisation has been granted for primary and secondary blister packaging of non-sterile oral solid dosage forms (tablets, capsules) under EU GMP requirements, supported by state-of-the-art qualified equipment and documented procedures. All packaged batches are subject to comprehensive quality control testing and Qualified Person certification prior to distribution, with full traceability of packaging materials, manufacturing parameters, control results and any deviations maintained in the batch record file.
3. QC testing
An in-house chemical and physical quality control laboratory has been established to perform release and stability testing on finished pharmaceutical products using validated analytical methods in accordance with ICH standards and registered specifications. The laboratory provides analytical method validation, technology transfer, and ICH-compliant stability studies, with a controlled retention sample storage system to maintain product references throughout the approved shelf-life. Microbiological quality control testing is outsourced to a GMP-compliant, accredited contract laboratory partner. The in-house chemical and physical laboratory is being developed for ISO/IEC 17025 accreditation to establish capability for independent contract analytical testing services.